Medical Care
Global Point-of-care Cancer Screening Market Research Report 2025
- Mar 11, 25
- ID: 14016
- Pages: 76
- Figures: 77
- Views: 1
The global market for Point-of-care Cancer Screening was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Point-of-care Cancer Screening is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Point-of-care Cancer Screening is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Point-of-care Cancer Screening in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Point-of-care Cancer Screening include Hologic Corporation, Abbott Laboratories, Qiagen N.V., F Hoffmann-La Roche, BD, Quest Diagnostics, OncoHealth Corp, Danaher, NOVIGENIX SA, Quidel Corporation, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Point-of-care Cancer Screening, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Point-of-care Cancer Screening.
The Point-of-care Cancer Screening market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Point-of-care Cancer Screening market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Point-of-care Cancer Screening companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Hologic Corporation
Abbott Laboratories
Qiagen N.V.
F Hoffmann-La Roche
BD
Quest Diagnostics
OncoHealth Corp
Danaher
NOVIGENIX SA
Quidel Corporation
Segment by Type
Genetic Screening
Image Screening
Others
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Point-of-care Cancer Screening company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
North American market for Point-of-care Cancer Screening is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Point-of-care Cancer Screening is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Point-of-care Cancer Screening in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Point-of-care Cancer Screening include Hologic Corporation, Abbott Laboratories, Qiagen N.V., F Hoffmann-La Roche, BD, Quest Diagnostics, OncoHealth Corp, Danaher, NOVIGENIX SA, Quidel Corporation, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Point-of-care Cancer Screening, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Point-of-care Cancer Screening.
The Point-of-care Cancer Screening market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Point-of-care Cancer Screening market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Point-of-care Cancer Screening companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Hologic Corporation
Abbott Laboratories
Qiagen N.V.
F Hoffmann-La Roche
BD
Quest Diagnostics
OncoHealth Corp
Danaher
NOVIGENIX SA
Quidel Corporation
Segment by Type
Genetic Screening
Image Screening
Others
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Point-of-care Cancer Screening company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Point-of-care Cancer Screening Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Genetic Screening
1.2.3 Image Screening
1.2.4 Others
1.3 Market by Application
1.3.1 Global Point-of-care Cancer Screening Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Point-of-care Cancer Screening Market Perspective (2020-2031)
2.2 Global Point-of-care Cancer Screening Growth Trends by Region
2.2.1 Global Point-of-care Cancer Screening Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Point-of-care Cancer Screening Historic Market Size by Region (2020-2025)
2.2.3 Point-of-care Cancer Screening Forecasted Market Size by Region (2026-2031)
2.3 Point-of-care Cancer Screening Market Dynamics
2.3.1 Point-of-care Cancer Screening Industry Trends
2.3.2 Point-of-care Cancer Screening Market Drivers
2.3.3 Point-of-care Cancer Screening Market Challenges
2.3.4 Point-of-care Cancer Screening Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Point-of-care Cancer Screening Players by Revenue
3.1.1 Global Top Point-of-care Cancer Screening Players by Revenue (2020-2025)
3.1.2 Global Point-of-care Cancer Screening Revenue Market Share by Players (2020-2025)
3.2 Global Point-of-care Cancer Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Point-of-care Cancer Screening Revenue
3.4 Global Point-of-care Cancer Screening Market Concentration Ratio
3.4.1 Global Point-of-care Cancer Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Point-of-care Cancer Screening Revenue in 2024
3.5 Global Key Players of Point-of-care Cancer Screening Head office and Area Served
3.6 Global Key Players of Point-of-care Cancer Screening, Product and Application
3.7 Global Key Players of Point-of-care Cancer Screening, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Point-of-care Cancer Screening Breakdown Data by Type
4.1 Global Point-of-care Cancer Screening Historic Market Size by Type (2020-2025)
4.2 Global Point-of-care Cancer Screening Forecasted Market Size by Type (2026-2031)
5 Point-of-care Cancer Screening Breakdown Data by Application
5.1 Global Point-of-care Cancer Screening Historic Market Size by Application (2020-2025)
5.2 Global Point-of-care Cancer Screening Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Point-of-care Cancer Screening Market Size (2020-2031)
6.2 North America Point-of-care Cancer Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Point-of-care Cancer Screening Market Size by Country (2020-2025)
6.4 North America Point-of-care Cancer Screening Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Point-of-care Cancer Screening Market Size (2020-2031)
7.2 Europe Point-of-care Cancer Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Point-of-care Cancer Screening Market Size by Country (2020-2025)
7.4 Europe Point-of-care Cancer Screening Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Point-of-care Cancer Screening Market Size (2020-2031)
8.2 Asia-Pacific Point-of-care Cancer Screening Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Point-of-care Cancer Screening Market Size by Region (2020-2025)
8.4 Asia-Pacific Point-of-care Cancer Screening Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Point-of-care Cancer Screening Market Size (2020-2031)
9.2 Latin America Point-of-care Cancer Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Point-of-care Cancer Screening Market Size by Country (2020-2025)
9.4 Latin America Point-of-care Cancer Screening Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Point-of-care Cancer Screening Market Size (2020-2031)
10.2 Middle East & Africa Point-of-care Cancer Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Point-of-care Cancer Screening Market Size by Country (2020-2025)
10.4 Middle East & Africa Point-of-care Cancer Screening Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Hologic Corporation
11.1.1 Hologic Corporation Company Details
11.1.2 Hologic Corporation Business Overview
11.1.3 Hologic Corporation Point-of-care Cancer Screening Introduction
11.1.4 Hologic Corporation Revenue in Point-of-care Cancer Screening Business (2020-2025)
11.1.5 Hologic Corporation Recent Development
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Details
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Point-of-care Cancer Screening Introduction
11.2.4 Abbott Laboratories Revenue in Point-of-care Cancer Screening Business (2020-2025)
11.2.5 Abbott Laboratories Recent Development
11.3 Qiagen N.V.
11.3.1 Qiagen N.V. Company Details
11.3.2 Qiagen N.V. Business Overview
11.3.3 Qiagen N.V. Point-of-care Cancer Screening Introduction
11.3.4 Qiagen N.V. Revenue in Point-of-care Cancer Screening Business (2020-2025)
11.3.5 Qiagen N.V. Recent Development
11.4 F Hoffmann-La Roche
11.4.1 F Hoffmann-La Roche Company Details
11.4.2 F Hoffmann-La Roche Business Overview
11.4.3 F Hoffmann-La Roche Point-of-care Cancer Screening Introduction
11.4.4 F Hoffmann-La Roche Revenue in Point-of-care Cancer Screening Business (2020-2025)
11.4.5 F Hoffmann-La Roche Recent Development
11.5 BD
11.5.1 BD Company Details
11.5.2 BD Business Overview
11.5.3 BD Point-of-care Cancer Screening Introduction
11.5.4 BD Revenue in Point-of-care Cancer Screening Business (2020-2025)
11.5.5 BD Recent Development
11.6 Quest Diagnostics
11.6.1 Quest Diagnostics Company Details
11.6.2 Quest Diagnostics Business Overview
11.6.3 Quest Diagnostics Point-of-care Cancer Screening Introduction
11.6.4 Quest Diagnostics Revenue in Point-of-care Cancer Screening Business (2020-2025)
11.6.5 Quest Diagnostics Recent Development
11.7 OncoHealth Corp
11.7.1 OncoHealth Corp Company Details
11.7.2 OncoHealth Corp Business Overview
11.7.3 OncoHealth Corp Point-of-care Cancer Screening Introduction
11.7.4 OncoHealth Corp Revenue in Point-of-care Cancer Screening Business (2020-2025)
11.7.5 OncoHealth Corp Recent Development
11.8 Danaher
11.8.1 Danaher Company Details
11.8.2 Danaher Business Overview
11.8.3 Danaher Point-of-care Cancer Screening Introduction
11.8.4 Danaher Revenue in Point-of-care Cancer Screening Business (2020-2025)
11.8.5 Danaher Recent Development
11.9 NOVIGENIX SA
11.9.1 NOVIGENIX SA Company Details
11.9.2 NOVIGENIX SA Business Overview
11.9.3 NOVIGENIX SA Point-of-care Cancer Screening Introduction
11.9.4 NOVIGENIX SA Revenue in Point-of-care Cancer Screening Business (2020-2025)
11.9.5 NOVIGENIX SA Recent Development
11.10 Quidel Corporation
11.10.1 Quidel Corporation Company Details
11.10.2 Quidel Corporation Business Overview
11.10.3 Quidel Corporation Point-of-care Cancer Screening Introduction
11.10.4 Quidel Corporation Revenue in Point-of-care Cancer Screening Business (2020-2025)
11.10.5 Quidel Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Point-of-care Cancer Screening Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Genetic Screening
1.2.3 Image Screening
1.2.4 Others
1.3 Market by Application
1.3.1 Global Point-of-care Cancer Screening Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Point-of-care Cancer Screening Market Perspective (2020-2031)
2.2 Global Point-of-care Cancer Screening Growth Trends by Region
2.2.1 Global Point-of-care Cancer Screening Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Point-of-care Cancer Screening Historic Market Size by Region (2020-2025)
2.2.3 Point-of-care Cancer Screening Forecasted Market Size by Region (2026-2031)
2.3 Point-of-care Cancer Screening Market Dynamics
2.3.1 Point-of-care Cancer Screening Industry Trends
2.3.2 Point-of-care Cancer Screening Market Drivers
2.3.3 Point-of-care Cancer Screening Market Challenges
2.3.4 Point-of-care Cancer Screening Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Point-of-care Cancer Screening Players by Revenue
3.1.1 Global Top Point-of-care Cancer Screening Players by Revenue (2020-2025)
3.1.2 Global Point-of-care Cancer Screening Revenue Market Share by Players (2020-2025)
3.2 Global Point-of-care Cancer Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Point-of-care Cancer Screening Revenue
3.4 Global Point-of-care Cancer Screening Market Concentration Ratio
3.4.1 Global Point-of-care Cancer Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Point-of-care Cancer Screening Revenue in 2024
3.5 Global Key Players of Point-of-care Cancer Screening Head office and Area Served
3.6 Global Key Players of Point-of-care Cancer Screening, Product and Application
3.7 Global Key Players of Point-of-care Cancer Screening, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Point-of-care Cancer Screening Breakdown Data by Type
4.1 Global Point-of-care Cancer Screening Historic Market Size by Type (2020-2025)
4.2 Global Point-of-care Cancer Screening Forecasted Market Size by Type (2026-2031)
5 Point-of-care Cancer Screening Breakdown Data by Application
5.1 Global Point-of-care Cancer Screening Historic Market Size by Application (2020-2025)
5.2 Global Point-of-care Cancer Screening Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Point-of-care Cancer Screening Market Size (2020-2031)
6.2 North America Point-of-care Cancer Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Point-of-care Cancer Screening Market Size by Country (2020-2025)
6.4 North America Point-of-care Cancer Screening Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Point-of-care Cancer Screening Market Size (2020-2031)
7.2 Europe Point-of-care Cancer Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Point-of-care Cancer Screening Market Size by Country (2020-2025)
7.4 Europe Point-of-care Cancer Screening Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Point-of-care Cancer Screening Market Size (2020-2031)
8.2 Asia-Pacific Point-of-care Cancer Screening Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Point-of-care Cancer Screening Market Size by Region (2020-2025)
8.4 Asia-Pacific Point-of-care Cancer Screening Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Point-of-care Cancer Screening Market Size (2020-2031)
9.2 Latin America Point-of-care Cancer Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Point-of-care Cancer Screening Market Size by Country (2020-2025)
9.4 Latin America Point-of-care Cancer Screening Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Point-of-care Cancer Screening Market Size (2020-2031)
10.2 Middle East & Africa Point-of-care Cancer Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Point-of-care Cancer Screening Market Size by Country (2020-2025)
10.4 Middle East & Africa Point-of-care Cancer Screening Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Hologic Corporation
11.1.1 Hologic Corporation Company Details
11.1.2 Hologic Corporation Business Overview
11.1.3 Hologic Corporation Point-of-care Cancer Screening Introduction
11.1.4 Hologic Corporation Revenue in Point-of-care Cancer Screening Business (2020-2025)
11.1.5 Hologic Corporation Recent Development
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Details
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Point-of-care Cancer Screening Introduction
11.2.4 Abbott Laboratories Revenue in Point-of-care Cancer Screening Business (2020-2025)
11.2.5 Abbott Laboratories Recent Development
11.3 Qiagen N.V.
11.3.1 Qiagen N.V. Company Details
11.3.2 Qiagen N.V. Business Overview
11.3.3 Qiagen N.V. Point-of-care Cancer Screening Introduction
11.3.4 Qiagen N.V. Revenue in Point-of-care Cancer Screening Business (2020-2025)
11.3.5 Qiagen N.V. Recent Development
11.4 F Hoffmann-La Roche
11.4.1 F Hoffmann-La Roche Company Details
11.4.2 F Hoffmann-La Roche Business Overview
11.4.3 F Hoffmann-La Roche Point-of-care Cancer Screening Introduction
11.4.4 F Hoffmann-La Roche Revenue in Point-of-care Cancer Screening Business (2020-2025)
11.4.5 F Hoffmann-La Roche Recent Development
11.5 BD
11.5.1 BD Company Details
11.5.2 BD Business Overview
11.5.3 BD Point-of-care Cancer Screening Introduction
11.5.4 BD Revenue in Point-of-care Cancer Screening Business (2020-2025)
11.5.5 BD Recent Development
11.6 Quest Diagnostics
11.6.1 Quest Diagnostics Company Details
11.6.2 Quest Diagnostics Business Overview
11.6.3 Quest Diagnostics Point-of-care Cancer Screening Introduction
11.6.4 Quest Diagnostics Revenue in Point-of-care Cancer Screening Business (2020-2025)
11.6.5 Quest Diagnostics Recent Development
11.7 OncoHealth Corp
11.7.1 OncoHealth Corp Company Details
11.7.2 OncoHealth Corp Business Overview
11.7.3 OncoHealth Corp Point-of-care Cancer Screening Introduction
11.7.4 OncoHealth Corp Revenue in Point-of-care Cancer Screening Business (2020-2025)
11.7.5 OncoHealth Corp Recent Development
11.8 Danaher
11.8.1 Danaher Company Details
11.8.2 Danaher Business Overview
11.8.3 Danaher Point-of-care Cancer Screening Introduction
11.8.4 Danaher Revenue in Point-of-care Cancer Screening Business (2020-2025)
11.8.5 Danaher Recent Development
11.9 NOVIGENIX SA
11.9.1 NOVIGENIX SA Company Details
11.9.2 NOVIGENIX SA Business Overview
11.9.3 NOVIGENIX SA Point-of-care Cancer Screening Introduction
11.9.4 NOVIGENIX SA Revenue in Point-of-care Cancer Screening Business (2020-2025)
11.9.5 NOVIGENIX SA Recent Development
11.10 Quidel Corporation
11.10.1 Quidel Corporation Company Details
11.10.2 Quidel Corporation Business Overview
11.10.3 Quidel Corporation Point-of-care Cancer Screening Introduction
11.10.4 Quidel Corporation Revenue in Point-of-care Cancer Screening Business (2020-2025)
11.10.5 Quidel Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Point-of-care Cancer Screening Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Genetic Screening
Table 3. Key Players of Image Screening
Table 4. Key Players of Others
Table 5. Global Point-of-care Cancer Screening Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Point-of-care Cancer Screening Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Point-of-care Cancer Screening Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Point-of-care Cancer Screening Market Share by Region (2020-2025)
Table 9. Global Point-of-care Cancer Screening Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Point-of-care Cancer Screening Market Share by Region (2026-2031)
Table 11. Point-of-care Cancer Screening Market Trends
Table 12. Point-of-care Cancer Screening Market Drivers
Table 13. Point-of-care Cancer Screening Market Challenges
Table 14. Point-of-care Cancer Screening Market Restraints
Table 15. Global Point-of-care Cancer Screening Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Point-of-care Cancer Screening Market Share by Players (2020-2025)
Table 17. Global Top Point-of-care Cancer Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point-of-care Cancer Screening as of 2024)
Table 18. Ranking of Global Top Point-of-care Cancer Screening Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Point-of-care Cancer Screening Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Point-of-care Cancer Screening, Headquarters and Area Served
Table 21. Global Key Players of Point-of-care Cancer Screening, Product and Application
Table 22. Global Key Players of Point-of-care Cancer Screening, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Point-of-care Cancer Screening Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Point-of-care Cancer Screening Revenue Market Share by Type (2020-2025)
Table 26. Global Point-of-care Cancer Screening Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Point-of-care Cancer Screening Revenue Market Share by Type (2026-2031)
Table 28. Global Point-of-care Cancer Screening Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Point-of-care Cancer Screening Revenue Market Share by Application (2020-2025)
Table 30. Global Point-of-care Cancer Screening Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Point-of-care Cancer Screening Revenue Market Share by Application (2026-2031)
Table 32. North America Point-of-care Cancer Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Point-of-care Cancer Screening Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Point-of-care Cancer Screening Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Point-of-care Cancer Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Point-of-care Cancer Screening Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Point-of-care Cancer Screening Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Point-of-care Cancer Screening Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Point-of-care Cancer Screening Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Point-of-care Cancer Screening Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Point-of-care Cancer Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Point-of-care Cancer Screening Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Point-of-care Cancer Screening Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Point-of-care Cancer Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Point-of-care Cancer Screening Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Point-of-care Cancer Screening Market Size by Country (2026-2031) & (US$ Million)
Table 47. Hologic Corporation Company Details
Table 48. Hologic Corporation Business Overview
Table 49. Hologic Corporation Point-of-care Cancer Screening Product
Table 50. Hologic Corporation Revenue in Point-of-care Cancer Screening Business (2020-2025) & (US$ Million)
Table 51. Hologic Corporation Recent Development
Table 52. Abbott Laboratories Company Details
Table 53. Abbott Laboratories Business Overview
Table 54. Abbott Laboratories Point-of-care Cancer Screening Product
Table 55. Abbott Laboratories Revenue in Point-of-care Cancer Screening Business (2020-2025) & (US$ Million)
Table 56. Abbott Laboratories Recent Development
Table 57. Qiagen N.V. Company Details
Table 58. Qiagen N.V. Business Overview
Table 59. Qiagen N.V. Point-of-care Cancer Screening Product
Table 60. Qiagen N.V. Revenue in Point-of-care Cancer Screening Business (2020-2025) & (US$ Million)
Table 61. Qiagen N.V. Recent Development
Table 62. F Hoffmann-La Roche Company Details
Table 63. F Hoffmann-La Roche Business Overview
Table 64. F Hoffmann-La Roche Point-of-care Cancer Screening Product
Table 65. F Hoffmann-La Roche Revenue in Point-of-care Cancer Screening Business (2020-2025) & (US$ Million)
Table 66. F Hoffmann-La Roche Recent Development
Table 67. BD Company Details
Table 68. BD Business Overview
Table 69. BD Point-of-care Cancer Screening Product
Table 70. BD Revenue in Point-of-care Cancer Screening Business (2020-2025) & (US$ Million)
Table 71. BD Recent Development
Table 72. Quest Diagnostics Company Details
Table 73. Quest Diagnostics Business Overview
Table 74. Quest Diagnostics Point-of-care Cancer Screening Product
Table 75. Quest Diagnostics Revenue in Point-of-care Cancer Screening Business (2020-2025) & (US$ Million)
Table 76. Quest Diagnostics Recent Development
Table 77. OncoHealth Corp Company Details
Table 78. OncoHealth Corp Business Overview
Table 79. OncoHealth Corp Point-of-care Cancer Screening Product
Table 80. OncoHealth Corp Revenue in Point-of-care Cancer Screening Business (2020-2025) & (US$ Million)
Table 81. OncoHealth Corp Recent Development
Table 82. Danaher Company Details
Table 83. Danaher Business Overview
Table 84. Danaher Point-of-care Cancer Screening Product
Table 85. Danaher Revenue in Point-of-care Cancer Screening Business (2020-2025) & (US$ Million)
Table 86. Danaher Recent Development
Table 87. NOVIGENIX SA Company Details
Table 88. NOVIGENIX SA Business Overview
Table 89. NOVIGENIX SA Point-of-care Cancer Screening Product
Table 90. NOVIGENIX SA Revenue in Point-of-care Cancer Screening Business (2020-2025) & (US$ Million)
Table 91. NOVIGENIX SA Recent Development
Table 92. Quidel Corporation Company Details
Table 93. Quidel Corporation Business Overview
Table 94. Quidel Corporation Point-of-care Cancer Screening Product
Table 95. Quidel Corporation Revenue in Point-of-care Cancer Screening Business (2020-2025) & (US$ Million)
Table 96. Quidel Corporation Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
Table 100. Authors List of This Report
List of Figures
Figure 1. Point-of-care Cancer Screening Picture
Figure 2. Global Point-of-care Cancer Screening Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Point-of-care Cancer Screening Market Share by Type: 2024 VS 2031
Figure 4. Genetic Screening Features
Figure 5. Image Screening Features
Figure 6. Others Features
Figure 7. Global Point-of-care Cancer Screening Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Point-of-care Cancer Screening Market Share by Application: 2024 VS 2031
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Others Case Studies
Figure 12. Point-of-care Cancer Screening Report Years Considered
Figure 13. Global Point-of-care Cancer Screening Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Point-of-care Cancer Screening Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Point-of-care Cancer Screening Market Share by Region: 2024 VS 2031
Figure 16. Global Point-of-care Cancer Screening Market Share by Players in 2024
Figure 17. Global Top Point-of-care Cancer Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point-of-care Cancer Screening as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Point-of-care Cancer Screening Revenue in 2024
Figure 19. North America Point-of-care Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Point-of-care Cancer Screening Market Share by Country (2020-2031)
Figure 21. United States Point-of-care Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Point-of-care Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Point-of-care Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Point-of-care Cancer Screening Market Share by Country (2020-2031)
Figure 25. Germany Point-of-care Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Point-of-care Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Point-of-care Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Point-of-care Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Point-of-care Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Point-of-care Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Point-of-care Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Point-of-care Cancer Screening Market Share by Region (2020-2031)
Figure 33. China Point-of-care Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Point-of-care Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Point-of-care Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Point-of-care Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Point-of-care Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Point-of-care Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Point-of-care Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Point-of-care Cancer Screening Market Share by Country (2020-2031)
Figure 41. Mexico Point-of-care Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Point-of-care Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Point-of-care Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Point-of-care Cancer Screening Market Share by Country (2020-2031)
Figure 45. Turkey Point-of-care Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Point-of-care Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Point-of-care Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Hologic Corporation Revenue Growth Rate in Point-of-care Cancer Screening Business (2020-2025)
Figure 49. Abbott Laboratories Revenue Growth Rate in Point-of-care Cancer Screening Business (2020-2025)
Figure 50. Qiagen N.V. Revenue Growth Rate in Point-of-care Cancer Screening Business (2020-2025)
Figure 51. F Hoffmann-La Roche Revenue Growth Rate in Point-of-care Cancer Screening Business (2020-2025)
Figure 52. BD Revenue Growth Rate in Point-of-care Cancer Screening Business (2020-2025)
Figure 53. Quest Diagnostics Revenue Growth Rate in Point-of-care Cancer Screening Business (2020-2025)
Figure 54. OncoHealth Corp Revenue Growth Rate in Point-of-care Cancer Screening Business (2020-2025)
Figure 55. Danaher Revenue Growth Rate in Point-of-care Cancer Screening Business (2020-2025)
Figure 56. NOVIGENIX SA Revenue Growth Rate in Point-of-care Cancer Screening Business (2020-2025)
Figure 57. Quidel Corporation Revenue Growth Rate in Point-of-care Cancer Screening Business (2020-2025)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Table 1. Global Point-of-care Cancer Screening Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Genetic Screening
Table 3. Key Players of Image Screening
Table 4. Key Players of Others
Table 5. Global Point-of-care Cancer Screening Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Point-of-care Cancer Screening Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Point-of-care Cancer Screening Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Point-of-care Cancer Screening Market Share by Region (2020-2025)
Table 9. Global Point-of-care Cancer Screening Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Point-of-care Cancer Screening Market Share by Region (2026-2031)
Table 11. Point-of-care Cancer Screening Market Trends
Table 12. Point-of-care Cancer Screening Market Drivers
Table 13. Point-of-care Cancer Screening Market Challenges
Table 14. Point-of-care Cancer Screening Market Restraints
Table 15. Global Point-of-care Cancer Screening Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Point-of-care Cancer Screening Market Share by Players (2020-2025)
Table 17. Global Top Point-of-care Cancer Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point-of-care Cancer Screening as of 2024)
Table 18. Ranking of Global Top Point-of-care Cancer Screening Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Point-of-care Cancer Screening Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Point-of-care Cancer Screening, Headquarters and Area Served
Table 21. Global Key Players of Point-of-care Cancer Screening, Product and Application
Table 22. Global Key Players of Point-of-care Cancer Screening, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Point-of-care Cancer Screening Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Point-of-care Cancer Screening Revenue Market Share by Type (2020-2025)
Table 26. Global Point-of-care Cancer Screening Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Point-of-care Cancer Screening Revenue Market Share by Type (2026-2031)
Table 28. Global Point-of-care Cancer Screening Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Point-of-care Cancer Screening Revenue Market Share by Application (2020-2025)
Table 30. Global Point-of-care Cancer Screening Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Point-of-care Cancer Screening Revenue Market Share by Application (2026-2031)
Table 32. North America Point-of-care Cancer Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Point-of-care Cancer Screening Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Point-of-care Cancer Screening Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Point-of-care Cancer Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Point-of-care Cancer Screening Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Point-of-care Cancer Screening Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Point-of-care Cancer Screening Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Point-of-care Cancer Screening Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Point-of-care Cancer Screening Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Point-of-care Cancer Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Point-of-care Cancer Screening Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Point-of-care Cancer Screening Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Point-of-care Cancer Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Point-of-care Cancer Screening Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Point-of-care Cancer Screening Market Size by Country (2026-2031) & (US$ Million)
Table 47. Hologic Corporation Company Details
Table 48. Hologic Corporation Business Overview
Table 49. Hologic Corporation Point-of-care Cancer Screening Product
Table 50. Hologic Corporation Revenue in Point-of-care Cancer Screening Business (2020-2025) & (US$ Million)
Table 51. Hologic Corporation Recent Development
Table 52. Abbott Laboratories Company Details
Table 53. Abbott Laboratories Business Overview
Table 54. Abbott Laboratories Point-of-care Cancer Screening Product
Table 55. Abbott Laboratories Revenue in Point-of-care Cancer Screening Business (2020-2025) & (US$ Million)
Table 56. Abbott Laboratories Recent Development
Table 57. Qiagen N.V. Company Details
Table 58. Qiagen N.V. Business Overview
Table 59. Qiagen N.V. Point-of-care Cancer Screening Product
Table 60. Qiagen N.V. Revenue in Point-of-care Cancer Screening Business (2020-2025) & (US$ Million)
Table 61. Qiagen N.V. Recent Development
Table 62. F Hoffmann-La Roche Company Details
Table 63. F Hoffmann-La Roche Business Overview
Table 64. F Hoffmann-La Roche Point-of-care Cancer Screening Product
Table 65. F Hoffmann-La Roche Revenue in Point-of-care Cancer Screening Business (2020-2025) & (US$ Million)
Table 66. F Hoffmann-La Roche Recent Development
Table 67. BD Company Details
Table 68. BD Business Overview
Table 69. BD Point-of-care Cancer Screening Product
Table 70. BD Revenue in Point-of-care Cancer Screening Business (2020-2025) & (US$ Million)
Table 71. BD Recent Development
Table 72. Quest Diagnostics Company Details
Table 73. Quest Diagnostics Business Overview
Table 74. Quest Diagnostics Point-of-care Cancer Screening Product
Table 75. Quest Diagnostics Revenue in Point-of-care Cancer Screening Business (2020-2025) & (US$ Million)
Table 76. Quest Diagnostics Recent Development
Table 77. OncoHealth Corp Company Details
Table 78. OncoHealth Corp Business Overview
Table 79. OncoHealth Corp Point-of-care Cancer Screening Product
Table 80. OncoHealth Corp Revenue in Point-of-care Cancer Screening Business (2020-2025) & (US$ Million)
Table 81. OncoHealth Corp Recent Development
Table 82. Danaher Company Details
Table 83. Danaher Business Overview
Table 84. Danaher Point-of-care Cancer Screening Product
Table 85. Danaher Revenue in Point-of-care Cancer Screening Business (2020-2025) & (US$ Million)
Table 86. Danaher Recent Development
Table 87. NOVIGENIX SA Company Details
Table 88. NOVIGENIX SA Business Overview
Table 89. NOVIGENIX SA Point-of-care Cancer Screening Product
Table 90. NOVIGENIX SA Revenue in Point-of-care Cancer Screening Business (2020-2025) & (US$ Million)
Table 91. NOVIGENIX SA Recent Development
Table 92. Quidel Corporation Company Details
Table 93. Quidel Corporation Business Overview
Table 94. Quidel Corporation Point-of-care Cancer Screening Product
Table 95. Quidel Corporation Revenue in Point-of-care Cancer Screening Business (2020-2025) & (US$ Million)
Table 96. Quidel Corporation Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
Table 100. Authors List of This Report
List of Figures
Figure 1. Point-of-care Cancer Screening Picture
Figure 2. Global Point-of-care Cancer Screening Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Point-of-care Cancer Screening Market Share by Type: 2024 VS 2031
Figure 4. Genetic Screening Features
Figure 5. Image Screening Features
Figure 6. Others Features
Figure 7. Global Point-of-care Cancer Screening Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Point-of-care Cancer Screening Market Share by Application: 2024 VS 2031
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Others Case Studies
Figure 12. Point-of-care Cancer Screening Report Years Considered
Figure 13. Global Point-of-care Cancer Screening Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Point-of-care Cancer Screening Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Point-of-care Cancer Screening Market Share by Region: 2024 VS 2031
Figure 16. Global Point-of-care Cancer Screening Market Share by Players in 2024
Figure 17. Global Top Point-of-care Cancer Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point-of-care Cancer Screening as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Point-of-care Cancer Screening Revenue in 2024
Figure 19. North America Point-of-care Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Point-of-care Cancer Screening Market Share by Country (2020-2031)
Figure 21. United States Point-of-care Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Point-of-care Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Point-of-care Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Point-of-care Cancer Screening Market Share by Country (2020-2031)
Figure 25. Germany Point-of-care Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Point-of-care Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Point-of-care Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Point-of-care Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Point-of-care Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Point-of-care Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Point-of-care Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Point-of-care Cancer Screening Market Share by Region (2020-2031)
Figure 33. China Point-of-care Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Point-of-care Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Point-of-care Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Point-of-care Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Point-of-care Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Point-of-care Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Point-of-care Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Point-of-care Cancer Screening Market Share by Country (2020-2031)
Figure 41. Mexico Point-of-care Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Point-of-care Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Point-of-care Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Point-of-care Cancer Screening Market Share by Country (2020-2031)
Figure 45. Turkey Point-of-care Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Point-of-care Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Point-of-care Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Hologic Corporation Revenue Growth Rate in Point-of-care Cancer Screening Business (2020-2025)
Figure 49. Abbott Laboratories Revenue Growth Rate in Point-of-care Cancer Screening Business (2020-2025)
Figure 50. Qiagen N.V. Revenue Growth Rate in Point-of-care Cancer Screening Business (2020-2025)
Figure 51. F Hoffmann-La Roche Revenue Growth Rate in Point-of-care Cancer Screening Business (2020-2025)
Figure 52. BD Revenue Growth Rate in Point-of-care Cancer Screening Business (2020-2025)
Figure 53. Quest Diagnostics Revenue Growth Rate in Point-of-care Cancer Screening Business (2020-2025)
Figure 54. OncoHealth Corp Revenue Growth Rate in Point-of-care Cancer Screening Business (2020-2025)
Figure 55. Danaher Revenue Growth Rate in Point-of-care Cancer Screening Business (2020-2025)
Figure 56. NOVIGENIX SA Revenue Growth Rate in Point-of-care Cancer Screening Business (2020-2025)
Figure 57. Quidel Corporation Revenue Growth Rate in Point-of-care Cancer Screening Business (2020-2025)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Circuit Simulator Market Research Report 2025
Mar 11, 25
Global Schematic Editor Market Research Report 2025
Mar 11, 25
Global Milk Green Tea Market Research Report 2025
Mar 11, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232